The latest molecular research have provided lots of insights to the procedures that govern the event and development of CLL, together with many novel mutated genes clustered in different functional pathways. The CLL epigenome is reprogrammed with the modulation of regulatory regions that appear de novo within the condition, whereas other regions pr